Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Methotrexate (oral liquid)

EU orphan designation number: EU/3/07/495   
Active ingredient: Methotrexate (oral liquid)
Indication: Treatment of acute lymphoblastic leukaemia
Sponsor: Orbona Pharma Ltd
Old Chambers, 93-94 West Street, Farnham, Surrey GU97EB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/10/2007 Centralised Orphan - Designation EMEA/OD/064/07 (2007)5297 of 24/10/2007
19/05/2014 Centralised Orphan - Transfer of orphan designation EMA/OD/064/07/T/01 (2014)3381 of 15/05/2014
04/10/2014 Other procedure